Micro- And Nanotechnologies-Based Product Development
Herausgeber: Mehra, Neelesh Kumar; Gulbake, Arvind
Micro- And Nanotechnologies-Based Product Development
Herausgeber: Mehra, Neelesh Kumar; Gulbake, Arvind
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book provides comprehensive information of the nanotechnological based pharmaceutical product development including diverse range of arena liposome, nanoparticles, fullerenes, hydrogels.
Andere Kunden interessierten sich auch für
- Design and Analysis of Clinical Trials with Time-to-Event Endpoints90,99 €
- Microbial Biotechnology112,99 €
- Mark ChangMonte Carlo Simulation for the Pharmaceutical Industry94,99 €
- Cyclic Nucleotide Phosphodiesterases in Health and Disease88,99 €
- Melissa Kurtis MicouA Laboratory Course in Tissue Engineering106,99 €
- Cholesterol-Lowering Therapy93,99 €
- Igor B Afanas'evSignaling Mechanisms of Oxygen and Nitrogen Free Radicals94,99 €
-
-
-
This book provides comprehensive information of the nanotechnological based pharmaceutical product development including diverse range of arena liposome, nanoparticles, fullerenes, hydrogels.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: CRC Press
- Seitenzahl: 312
- Erscheinungstermin: 7. Oktober 2024
- Englisch
- Abmessung: 279mm x 210mm x 18mm
- Gewicht: 739g
- ISBN-13: 9781032050720
- ISBN-10: 1032050721
- Artikelnr.: 71600595
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: CRC Press
- Seitenzahl: 312
- Erscheinungstermin: 7. Oktober 2024
- Englisch
- Abmessung: 279mm x 210mm x 18mm
- Gewicht: 739g
- ISBN-13: 9781032050720
- ISBN-10: 1032050721
- Artikelnr.: 71600595
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Dr. Neelesh Kumar Mehra is working as an Assistant Professor of Pharmaceutics & Biopharmaceutics, at the Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, India. He earned his PhD from Dr. H.S. Gour University, Sagar and PostDoc from Irma Lerma Rangel College of Pharmacy, Texas A & M Health Science Centre, Kingsville, TX, USA. He served as Manager in Product Development, Sentiss Research Centre, Sentiss Pharma Pvt Ltd. Gurgaon for development, scale-up and technology transfer of complex ophthalmic, inhalation and optic pharmaceutical products. He received 'TEAM AWARD' for successful commercialisation of Ophthalmic Suspension product. He has authored more than 60 peer-reviewed publications in high repute International Journals, and >10 book chapter contributions. He has filed patent on manufacturing process and composition to improved therapeutic efficacy for topical delivery. He guided PhD and M.S. students for their dissertations/research projects. He has received numerous outstanding awards including Young Scientist and Team Awards for their research output. He is a peer reviewer of various international Journals and publishers. He recently published one edited book "Dendrimers in Nanomedicine Concept, Theory and Regulatory Perspectives" in CRC Press. Currently, he is editing books on Biopharmaceutical and nanotechnology based with Elsevier Pvt Ltd. He has rich research and teaching experience in the formulation and development of complex, innovative ophthalmic and injectable biopharmaceutical products including micro- and nanotechnologies for regulated market and so on. Dr. Arvind Gulbake is working as an Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical & Population Health Informatics at DIT University, Dehradun. Earlier, he was worked as a Coordinator, Research & Development, Centre for Interdisciplinary Research, D.Y. Patil Education Society, Institutions Deemed to be University, Kolhapur, Maharashtra, India. He earned his PhD with Prof. Sanjay K. Jain from Dr. Harisingh Gour University, Sagar. He has authored more than 40 peer-reviewed publications in high repute International Journals, 4 book chapters and a patent contribution. He guided PhD and M.S. students for their dissertations/research projects. He successfully completed extramural project funded by SERB, New Delhi, Government of India. He has received outstanding awards including Young Scientist and BRG Travel Award for his research. He is a peer reviewer of various International Journals and publishers. He is an assistant editor for International Journal of Applied Pharmaceutics and editorial board member in Journal of Liposome Research. He is a member of various academic committees at University level i.e., Board of Studies (Masters and Ph.D.), IBSC, IAEC, IQAC and Institutional Research Committee. He has more than 12 years of research and teaching experience in the formulation and development of nanopharmaceuticals
Section A Introduction Chapter 1 Micro- and Nanotechnology Approaches:
Concepts and Applications Chapter 2 Formulation by Design (FbD): An
Emerging Approach to Design Vesicular Nanocarriers Chapter 3 Thermally
Responsive Externally Activated Theranostics (TREAT) for On-Demand
Multifunctional Drug Delivery Systems Chapter 4 C60-Fullerenes as an
Emerging Cargo Carrier for the Delivery of Anti-Neoplastic Agents: Promises
and Challenges Section B Bioactive Delivery Systems Chapter 5
Pharmaceutical and Biomedical Applications of Multifunctional Quantum Dots
Chapter 6 PLGA-Based Micro- and Nano-particles: From Lab to Market Chapter
7 Targeted Lipid-Based Nanoparticles for Nucleic Acid Delivery in Cancer
Therapy Chapter 8 Formulation Strategies for Improved Ophthalmic Delivery
of Hydrophilic Drugs Chapter 9 Metal Nanoparticles as a Surrogate Carrier
in Drug Delivery and Diagnostics Chapter 10 Resealed Erythrocytes: A
Biological Carrier for Drug Delivery Chapter 11 Nanostructured
Hydrogel-Based Biosensor Platform Chapter 12 Multifunctional Carbon
Nanotubes in Drug Delivery Section C Product Development, Toxicity and
Scale-Up Chapter 13 Liposomal-Based Pharmaceutical Formulations ¿ Current
Landscape, Limitations and Technologies for Industrial Scale-Up Chapter 14
Impact and Role of Stability Studies in Parenteral Product Development
Chapter 15 Reverse Engineering in Pharmaceutical Product Development
Chapter 16 Role of Polymers in Formulation Design and Drug Delivery Chapter
17 Drug Delivery Systems for Targeting Blood Brain Barrier: Examples of
nanomedicines for the treatment of neurodegenerative diseases Chapter 18
Validation, Scale-Up and Technology Transfer in Product Development Chapter
19 Nanotoxicology: Safety, Toxicity and Regulatory Considerations
Concepts and Applications Chapter 2 Formulation by Design (FbD): An
Emerging Approach to Design Vesicular Nanocarriers Chapter 3 Thermally
Responsive Externally Activated Theranostics (TREAT) for On-Demand
Multifunctional Drug Delivery Systems Chapter 4 C60-Fullerenes as an
Emerging Cargo Carrier for the Delivery of Anti-Neoplastic Agents: Promises
and Challenges Section B Bioactive Delivery Systems Chapter 5
Pharmaceutical and Biomedical Applications of Multifunctional Quantum Dots
Chapter 6 PLGA-Based Micro- and Nano-particles: From Lab to Market Chapter
7 Targeted Lipid-Based Nanoparticles for Nucleic Acid Delivery in Cancer
Therapy Chapter 8 Formulation Strategies for Improved Ophthalmic Delivery
of Hydrophilic Drugs Chapter 9 Metal Nanoparticles as a Surrogate Carrier
in Drug Delivery and Diagnostics Chapter 10 Resealed Erythrocytes: A
Biological Carrier for Drug Delivery Chapter 11 Nanostructured
Hydrogel-Based Biosensor Platform Chapter 12 Multifunctional Carbon
Nanotubes in Drug Delivery Section C Product Development, Toxicity and
Scale-Up Chapter 13 Liposomal-Based Pharmaceutical Formulations ¿ Current
Landscape, Limitations and Technologies for Industrial Scale-Up Chapter 14
Impact and Role of Stability Studies in Parenteral Product Development
Chapter 15 Reverse Engineering in Pharmaceutical Product Development
Chapter 16 Role of Polymers in Formulation Design and Drug Delivery Chapter
17 Drug Delivery Systems for Targeting Blood Brain Barrier: Examples of
nanomedicines for the treatment of neurodegenerative diseases Chapter 18
Validation, Scale-Up and Technology Transfer in Product Development Chapter
19 Nanotoxicology: Safety, Toxicity and Regulatory Considerations
Section A Introduction Chapter 1 Micro- and Nanotechnology Approaches:
Concepts and Applications Chapter 2 Formulation by Design (FbD): An
Emerging Approach to Design Vesicular Nanocarriers Chapter 3 Thermally
Responsive Externally Activated Theranostics (TREAT) for On-Demand
Multifunctional Drug Delivery Systems Chapter 4 C60-Fullerenes as an
Emerging Cargo Carrier for the Delivery of Anti-Neoplastic Agents: Promises
and Challenges Section B Bioactive Delivery Systems Chapter 5
Pharmaceutical and Biomedical Applications of Multifunctional Quantum Dots
Chapter 6 PLGA-Based Micro- and Nano-particles: From Lab to Market Chapter
7 Targeted Lipid-Based Nanoparticles for Nucleic Acid Delivery in Cancer
Therapy Chapter 8 Formulation Strategies for Improved Ophthalmic Delivery
of Hydrophilic Drugs Chapter 9 Metal Nanoparticles as a Surrogate Carrier
in Drug Delivery and Diagnostics Chapter 10 Resealed Erythrocytes: A
Biological Carrier for Drug Delivery Chapter 11 Nanostructured
Hydrogel-Based Biosensor Platform Chapter 12 Multifunctional Carbon
Nanotubes in Drug Delivery Section C Product Development, Toxicity and
Scale-Up Chapter 13 Liposomal-Based Pharmaceutical Formulations ¿ Current
Landscape, Limitations and Technologies for Industrial Scale-Up Chapter 14
Impact and Role of Stability Studies in Parenteral Product Development
Chapter 15 Reverse Engineering in Pharmaceutical Product Development
Chapter 16 Role of Polymers in Formulation Design and Drug Delivery Chapter
17 Drug Delivery Systems for Targeting Blood Brain Barrier: Examples of
nanomedicines for the treatment of neurodegenerative diseases Chapter 18
Validation, Scale-Up and Technology Transfer in Product Development Chapter
19 Nanotoxicology: Safety, Toxicity and Regulatory Considerations
Concepts and Applications Chapter 2 Formulation by Design (FbD): An
Emerging Approach to Design Vesicular Nanocarriers Chapter 3 Thermally
Responsive Externally Activated Theranostics (TREAT) for On-Demand
Multifunctional Drug Delivery Systems Chapter 4 C60-Fullerenes as an
Emerging Cargo Carrier for the Delivery of Anti-Neoplastic Agents: Promises
and Challenges Section B Bioactive Delivery Systems Chapter 5
Pharmaceutical and Biomedical Applications of Multifunctional Quantum Dots
Chapter 6 PLGA-Based Micro- and Nano-particles: From Lab to Market Chapter
7 Targeted Lipid-Based Nanoparticles for Nucleic Acid Delivery in Cancer
Therapy Chapter 8 Formulation Strategies for Improved Ophthalmic Delivery
of Hydrophilic Drugs Chapter 9 Metal Nanoparticles as a Surrogate Carrier
in Drug Delivery and Diagnostics Chapter 10 Resealed Erythrocytes: A
Biological Carrier for Drug Delivery Chapter 11 Nanostructured
Hydrogel-Based Biosensor Platform Chapter 12 Multifunctional Carbon
Nanotubes in Drug Delivery Section C Product Development, Toxicity and
Scale-Up Chapter 13 Liposomal-Based Pharmaceutical Formulations ¿ Current
Landscape, Limitations and Technologies for Industrial Scale-Up Chapter 14
Impact and Role of Stability Studies in Parenteral Product Development
Chapter 15 Reverse Engineering in Pharmaceutical Product Development
Chapter 16 Role of Polymers in Formulation Design and Drug Delivery Chapter
17 Drug Delivery Systems for Targeting Blood Brain Barrier: Examples of
nanomedicines for the treatment of neurodegenerative diseases Chapter 18
Validation, Scale-Up and Technology Transfer in Product Development Chapter
19 Nanotoxicology: Safety, Toxicity and Regulatory Considerations